Literature DB >> 14996142

A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders.

Russell T Joffe1, Glenda M MacQueen, Michael Marriott, L Trevor Young.   

Abstract

BACKGROUND: There is a recent appreciation that patients with bipolar disorder spend a substantial period of time with minor or subsyndromal mood symptoms both manic and depressive. This study examined time spent in minor and subsyndromal mood states as well as with mania and depression in a cohort of well characterized bipolar I and II patients who were followed prospectively for an average of three years.
METHOD: Detailed life-charting data were obtained from 138 patients with bipolar disorder. Mood states were characterized as euthymic, subsyndromal, minor or major affective episodes based on rigorously defined criteria. The amount of time spent in these mood states during follow-up was examined.
RESULTS: Patients in the total sample and within each bipolar subtype spent approximately half of their time euthymic. The remainder of the time was spent in varying severity of mood states. However, the majority of time was spent with minor and subsyndromal symptoms, both manic and depressive. Bipolar I patients differ from bipolar II in that significantly more time was spent with subsyndromal, minor and manic symptoms. There was no difference in time spent with depressive symptoms between the two groups.
CONCLUSIONS: Patients with bipolar disorder spend a substantial proportion of time with depressive or manic symptoms with the preponderance being minor or subsyndromal. Awareness of subthreshold symptoms in bipolar disorders and treatment of such symptoms may be improved by establishing guidelines that specifically outline appropriate strategies for reducing the duration of subsyndromal symptoms in bipolar disorder.

Entities:  

Mesh:

Year:  2004        PMID: 14996142     DOI: 10.1046/j.1399-5618.2003.00091.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  29 in total

1.  Cognition and the differential diagnosis of schizophrenia.

Authors:  Philip D Harvey
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

Review 2.  Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.

Authors:  Michael W Jann
Journal:  Am Health Drug Benefits       Date:  2014-12

3.  Hypersomnia in inter-episode bipolar disorder: does it have prognostic significance?

Authors:  Katherine A Kaplan; June Gruber; Polina Eidelman; Lisa S Talbot; Allison G Harvey
Journal:  J Affect Disord       Date:  2011-04-13       Impact factor: 4.839

4.  You'll feel better in the morning: slow wave activity and overnight mood regulation in interepisode bipolar disorder.

Authors:  A M Soehner; K A Kaplan; J M Saletin; L S Talbot; I S Hairston; J Gruber; P Eidelman; M P Walker; A G Harvey
Journal:  Psychol Med       Date:  2017-06-19       Impact factor: 7.723

5.  Interventions for Sleep Disturbance in Bipolar Disorder.

Authors:  Allison G Harvey; Katherine A Kaplan; Adriane M Soehner
Journal:  Sleep Med Clin       Date:  2015-03

6.  Chronic stressors and trauma: prospective influences on the course of bipolar disorder.

Authors:  A Gershon; S L Johnson; I Miller
Journal:  Psychol Med       Date:  2013-02-18       Impact factor: 7.723

7.  Are adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry.

Authors:  Carol A Janney; Andrea Fagiolini; Holly A Swartz; John M Jakicic; Robert G Holleman; Caroline R Richardson
Journal:  J Affect Disord       Date:  2013-09-18       Impact factor: 4.839

8.  Restless pillow, ruffled mind: sleep and affect coupling in interepisode bipolar disorder.

Authors:  Anda Gershon; Wesley K Thompson; Polina Eidelman; Eleanor L McGlinchey; Katherine A Kaplan; Allison G Harvey
Journal:  J Abnorm Psychol       Date:  2012-07-30

9.  Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials.

Authors:  Keming Gao; Marcia L Verduin; David E Kemp; Bryan K Tolliver; Stephen J Ganocy; Omar Elhaj; Sarah Bilali; Kathleen T Brady; Robert L Findling; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

Review 10.  Options for pharmacological treatment of refractory bipolar depression.

Authors:  Leonardo Tondo; Gustavo H Vázquez; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.